RPI Structural Bioinformatics Lab
The Rensselaer Polytechnic Institute Structural Bioinformatics Laboratory pursues dynamic structure – function studies of proteins. The lab combines computational methods with biophysical data to elucidate mechanisms of biological processes.
Proposed mechanism by which FDA-approved hepatitis C virus (HCV) drugs synergize with the SARS-CoV-2 antiviral remdesivir
Research Highlights
A common binding motif in the ET domain of BRD3 forms polymorphic structural interfaces with host and viral proteins. Structure (Cell Press) 2021 Article
Hepatitis C virus drugs inhibit SARS-CoV-2 PLpro and act synergistically with the antiviral remdesivir. Cell Reports 2021
Interdomain dynamics in a complex formed between Maloney Leukemia Virus and a host chromatin-associated protein
Milestones
Congratulations to Ms. Jingzhou Hao, accepted to the Graduate Program in Molecular Biophysics at Johns Hopkins University.
Congratulations to Nobuyasu Koga, Rie Koga, Gaohua Liu, Javier Castellanos, and David Baker on publication our joint study Role of backbone strain in de novo design of complex α/β protein structures. Nature Communications 2021.
..
Harold A. Scheraga
Harold was gifted with a unique combination of intensity and breadth of vision. He realized early in his career that both experimental and theoretical work would be necessary to solve the central problems of protein science, and, most unusually, he excelled in both spheres.
Statement of Accesability: https://info.rpi.edu/statement-of-accessibility